0000905148-24-001143.txt : 20240409 0000905148-24-001143.hdr.sgml : 20240409 20240409193601 ACCESSION NUMBER: 0000905148-24-001143 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240405 FILED AS OF DATE: 20240409 DATE AS OF CHANGE: 20240409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Strobeck Matthew CENTRAL INDEX KEY: 0001377832 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39659 FILM NUMBER: 24833927 MAIL ADDRESS: STREET 1: C/O METABOLIX, INC. STREET 2: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODESIX INC CENTRAL INDEX KEY: 0001439725 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 203986492 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2970 WILDERNESS PLACE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-417-0500 MAIL ADDRESS: STREET 1: 2970 WILDERNESS PLACE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 4 1 form4.xml X0508 4 2024-04-05 0001439725 BIODESIX INC BDSX 0001377832 Strobeck Matthew 919 WEST DILLON RD LOUISVILLE CO 80027 true false Series A Non-Voting Convertible Preferred Stock 2024-04-05 4 A 0 1304 46 A Common Stock 52160 1304 I By Birchview Capital Separately Managed Account Series A Non-Voting Convertible Preferred Stock 2024-04-05 4 A 0 7392 46 A Common Stock 295680 7392 I By Birchview Fund LLC These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the "Conversion Proposal"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date. The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. /s/ Robin H. Cowie as Attorney-in-Fact for Matthew Strobeck 2024-04-09